Both test biomarkers used in this study are known to be differentially expressed in the tumour compartment of different colorectal cancer cases ranging from absence of expression through to high level of expression on tumour epithelial cells for PD-L1 [25], or from low to high numbers of expressing cells for c-MET [26-27]. The gene discussed is MET; the disease is colorectal cancer.